The epithalamin-treated group also had reduced rates of coronary artery disease, hypertension, and osteoarthritis, compared to the control group participants [6]
Researchers are looking into its applications beyond weight loss, where it could potentially serve as a therapeutic agent for obesity and related metabolic disorders
On the second day of the meeting, discussions on three other peptides emideltide, epitalon, and semax were underway
Not by grand pronouncements or miracle cures, but by small molecules doing precise work at the cellular level
Follow your medications specific guidelines for taking late doses
Originally, they considered that the risk of cardiovascular disease associated with obesity resulted in higher costs than covering these medications for weight loss